Faculty

Back to Index
Deepa Bhojwani, MBBS, DCH
Associate Professor of Clinical Pediatrics
Pediatrics
CHLA 4650 W. Sunset Blvd. Off Campus Los Angeles

Publications

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia. J Clin Oncol. 2016 Dec 20; 34(36):4381-4389. View in: PubMed

Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP. Genome Res. 2016 Nov 30. View in: PubMed

Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis. Lancet Haematol. 2016 Oct; 3(10):e456-e466. View in: PubMed

The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia. Pediatr Blood Cancer. 2016 Sep; 63(9):1546-51. View in: PubMed

Wyburn Mason Syndrome: A Rare Phacomatosis. Ophthalmology. 2016 Aug; 123(8):1787. View in: PubMed

Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia. J Clin Oncol. 2016 Jun 20; 34(18):2133-40. View in: PubMed

NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet. 2016 Apr; 48(4):367-73. View in: PubMed

Idiopathic bilateral uveal effusion syndrome (UES) in a middle-aged woman. Indian J Med Res. 2015 Nov; 142(5):623-4. View in: PubMed

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000. View in: PubMed

NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells. Nat Genet. 2015 Jun; 47(6):607-14. View in: PubMed

Giant nevus of Ota. Indian J Ophthalmol. 2015 Jun; 63(6):532-3. View in: PubMed

Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. Lancet Oncol. 2015 Apr; 16(4):465-74. View in: PubMed

Bietti crystalline dystrophy in a young woman. JAMA Ophthalmol. 2015 Mar 12; 133(3):e143514. View in: PubMed

The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma. Br J Haematol. 2015 Mar; 168(6):845-53. View in: PubMed

Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. J Clin Oncol. 2015 Feb 20; 33(6):610-5. View in: PubMed

Biology of childhood acute lymphoblastic leukemia. Pediatr Clin North Am. 2015 Feb; 62(1):47-60. View in: PubMed

A revised definition for cure of childhood acute lymphoblastic leukemia. Leukemia. 2014 Dec; 28(12):2336-43. View in: PubMed

Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia. Eur J Cancer. 2014 Oct; 50(15):2685-94. View in: PubMed

How accurate is the diagnosis of diabetic retinopathy on telescreening? The Indian scenario. Rural Remote Health. 2014 Oct-Dec; 14(4):2809. View in: PubMed

Systemic lupus erythematosus retinopathy in a 32-year-old female: Report of a case. Indian J Ophthalmol. 2014 Sep; 62(9):951-2. View in: PubMed

Unilateral Punctate inner choroidopathy with choroidal neovascular membrane in a young male. Indian J Ophthalmol. 2014 Sep; 62(9):949-50. View in: PubMed

A Phase I Study of EZN-3042, a Novel Survivin Messenger Ribonucleic Acid (mRNA) Antagonist, Administered in Combination With Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL): A Report From the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium. J Pediatr Hematol Oncol. 2014 Aug; 36(6):458-63. View in: PubMed

Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes. Pharmacogenomics. 2014 Jun; 15(8):1065-78. View in: PubMed

Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer. 2014 May 15; 120(10):1514-9. View in: PubMed

Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol. 2014 Mar 20; 32(9):949-59. View in: PubMed

Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet. 2013 Dec; 45(12):1494-8. View in: PubMed

HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia. Leuk Lymphoma. 2013 Nov; 54(11):2565-7. View in: PubMed

A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat Genet. 2013 Oct; 45(10):1226-31. View in: PubMed

Results of treatment of advanced-stage lymphoblastic lymphoma at St Jude Children's Research Hospital from 1962 to 2002. Ann Oncol. 2013 Sep; 24(9):2425-9. View in: PubMed

Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2013 Jun 10; 31(17):2182-8. View in: PubMed

Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemia. Cancer. 2013 Jun 1; 119(11):2061-6. View in: PubMed

Novel susceptibility variants at 10p12. 31-12. 2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst. 2013 May 15; 105(10):733-42. View in: PubMed

Relapsed childhood acute lymphoblastic leukaemia. Lancet Oncol. 2013 May; 14(6):e205-17. View in: PubMed

Thiopurine S-methyltransferase pharmacogenetics in childhood acute lymphoblastic leukemia. Methods Mol Biol. 2013; 999:273-84. View in: PubMed

ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia. 2012 Feb; 26(2):265-70. View in: PubMed

Endogenous knockdown of survivin improves chemotherapeutic response in ALL models. Leukemia. 2012 Feb; 26(2):271-9. View in: PubMed

Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling. Blood. 2012 Jan 19; 119(3):817-25. View in: PubMed

Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies. Br J Haematol. 2012 Jan; 156(2):275-9. View in: PubMed

Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood. 2011 Nov 10; 118(19):5218-26. View in: PubMed

Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles. Leukemia. 2011 Oct; 25(10):1555-63. View in: PubMed

Spinal epidural lipomatosis in children with hematologic malignancies. Ann Hematol. 2011 Sep; 90(9):1067-74. View in: PubMed

Improved prognosis for older adolescents with acute lymphoblastic leukemia. J Clin Oncol. 2011 Feb 1; 29(4):386-91. View in: PubMed

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 2010 Dec 2; 116(23):4874-84. View in: PubMed

Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia. Br J Haematol. 2010 Aug; 150(3):352-8. View in: PubMed

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood. 2010 Feb 18; 115(7):1394-405. View in: PubMed

Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia. 2010 Feb; 24(2):371-82. View in: PubMed

Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med. 2010 Jan 7; 362(1):88-9. View in: PubMed

High-risk childhood acute lymphoblastic leukemia. Clin Lymphoma Myeloma. 2009; 9 Suppl 3:S222-30. View in: PubMed

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood. 2008 Nov 15; 112(10):4178-83. View in: PubMed

Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]. J Clin Oncol. 2008 Sep 20; 26(27):4376-84. View in: PubMed

T-cell PTLD presenting as acalculous cholecystitis. Pediatr Transplant. 2008 Sep; 12(6):717-20. View in: PubMed

Intrathecal liposomal cytarabine: more friend than foe? Leuk Lymphoma. Intrathecal liposomal cytarabine: more friend than foe? Leuk Lymphoma. 2008 Aug; 49(8):1427-30. View in: PubMed

Potential of gene expression profiling in the management of childhood acute lymphoblastic leukemia. Paediatr Drugs. 2007; 9(3):149-56. View in: PubMed

Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer. 2006 Aug; 47(2):130-40. View in: PubMed

Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 2006 Jul 15; 108(2):711-7. View in: PubMed

Childhood acute lymphoblastic leukemia in the age of genomics. Pediatr Blood Cancer. 2006 May 1; 46(5):570-8. View in: PubMed

Thrombophilia in childhood. Curr Probl Pediatr Adolesc Health Care. 2004 May-Jun; 34(5):190-212. View in: PubMed

Pediatric acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2003; 102-31. View in: PubMed

Powered bySC CTSI